Longevity Health Holdings, Inc.
XAGE
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -99.45% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -99.45% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 67.75% | -15.66% | 113.76% | 68.77% | 81.70% |
| Depreciation & Amortization | 2.13% | -22.03% | -22.41% | -10.65% | -2.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.13% | 207.63% | -32.13% | -19.07% | 8.27% |
| Operating Income | -9.16% | -202.37% | 33.09% | 19.89% | -8.27% |
| Income Before Tax | 57.62% | -11,266.29% | 68.22% | 37.76% | -94.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.62% | -10,173.03% | 68.22% | 37.76% | -94.30% |
| Earnings from Discontinued Operations | -- | -100.00% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.96% | -128.96% | 74.89% | 37.76% | -78.87% |
| EBIT | -9.16% | -202.37% | 33.09% | 19.89% | -8.27% |
| EBITDA | -9.29% | -219.46% | 33.21% | 20.06% | -8.47% |
| EPS Basic | 64.52% | -132.51% | 77.72% | 96.81% | 92.51% |
| Normalized Basic EPS | 67.34% | -12,680.28% | 69.69% | 96.62% | 90.48% |
| EPS Diluted | 64.52% | -132.51% | 77.72% | 96.81% | 92.51% |
| Normalized Diluted EPS | 67.34% | -12,680.28% | 69.69% | 96.62% | 90.48% |
| Average Basic Shares Outstanding | 29.77% | -10.95% | 12.21% | 1,743.20% | 1,942.25% |
| Average Diluted Shares Outstanding | 29.77% | -10.95% | 12.21% | 1,743.20% | 1,942.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |